
Companion Animal Diagnostics Market Report 2026
Global Outlook – By Animal Type (Cat, Horse, Dog, Other Animal Types), By Technology (Immunodiagnostics, Clinical Biochemistry, Hematology, Urinalysis, Molecular Diagnostics, Other Technologies), By Application (Bacteriology, Clinical Pathology, Virology, Parasitology, Other Applications), By End-Users (Diagnostics Laboratories, Veterinary Clinics And Hospitals, Research Institutes, Home Care Settings) - Market Size, Trends, And Global Forecast 2026-2035
Companion Animal Diagnostics Market Overview
• Companion Animal Diagnostics market size has reached to $3.4 billion in 2025 • Expected to grow to $5.37 billion in 2030 at a compound annual growth rate (CAGR) of 9.5% • Growth Driver: Rising Number Of Pet Owners Fuels Growth In Companion Animal Diagnostics • Market Trend: Expansion Of Reference Laboratories To Boost Remote Diagnostic Capabilities In Companion Animal Care • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Companion Animal Diagnostics Market?
Companion animal diagnostics refers to the testing and diagnostic procedures used to identify and manage health conditions in pets, such as dogs and cats. This includes a range of tools and services, from blood tests and imaging to specialized assays. It offers early detection and precise management of health conditions, leading to improved outcomes and tailored treatment plans. The main animal types of companion animal diagnostics are cats, horses, dogs, and others. The cat diagnostics includes all diagnostic products and services specifically designed for feline health. This covers tools and tests used to detect, monitor, and manage diseases in cats, such as blood tests, imaging, and genetic screening. The technologies include immunodiagnostics, clinical biochemistry, hematology, urinalysis, molecular diagnostics, and others. They are used for different applications, including bacteriology, clinical pathology, virology, parasitology, and others and end-users are diagnostic laboratories, veterinary clinics and hospitals, research institutes, and home care settings.
What Is The Companion Animal Diagnostics Market Size and Share 2026?
The companion animal diagnostics market size has grown strongly in recent years. It will grow from $3.4 billion in 2025 to $3.74 billion in 2026 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to rising pet ownership rates, increasing expenditure on companion animal healthcare, expansion of veterinary diagnostic laboratories, growing awareness of preventive pet care, availability of advanced veterinary testing technologies.What Is The Companion Animal Diagnostics Market Growth Forecast?
The companion animal diagnostics market size is expected to see strong growth in the next few years. It will grow to $5.37 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to increasing demand for personalized veterinary medicine, rising adoption of advanced molecular diagnostics, expansion of home-based pet testing solutions, growing investments in veterinary healthcare infrastructure, increasing focus on early disease detection in pets. Major trends in the forecast period include increasing adoption of point-of-care diagnostic tests, rising use of molecular diagnostics in veterinary care, growing integration of digital diagnostic platforms, expansion of preventive health screening for pets, enhanced focus on rapid and accurate testing.Global Companion Animal Diagnostics Market Segmentation
1) By Animal Type: Cat, Horse, Dog, Other Animal Types 2) By Technology: Immunodiagnostics, Clinical Biochemistry, Hematology, Urinalysis, Molecular Diagnostics, Other Technologies 3) By Application: Bacteriology, Clinical Pathology, Virology, Parasitology, Other Applications 4) By End-Users: Diagnostics Laboratories, Veterinary Clinics And Hospitals, Research Institutes, Home Care Settings Subsegments: 1) By Cat: Feline Infectious Disease Testing, Feline Blood Tests, Feline Urinalysis 2) By Horse: Equine Infectious Disease Testing, Equine Blood Tests, Equine Diagnostic Imaging 3) By Dog: Canine Infectious Disease Testing, Canine Blood Tests, Canine Urinalysis 4) By Other Animal Types: Small Mammals, Birds, Reptiles, Exotic PetsWhat Is The Driver Of The Companion Animal Diagnostics Market?
The rising number of pet owners is expected to propel the growth of the companion animal diagnostics market going forward. Pet owners are individuals who possess and take responsibility for the care, well-being, and management of pets. More people are owning pets due to increased recognition of their emotional and health benefits and the rise in accessible pet-related services and products. Companion animal diagnostics help pet owners by providing essential health information and early detection of diseases in their pets, ensuring timely and effective care. For instance, in March 2025, according to the American Pet Products Association (APPA), a leading US-based nonprofit trade association for the pet products industry, about 94 million US households owned at least one pet in 2024, up from 82 million in 2023, and in 2024, roughly 18.8 million (20%) of those pet-owning households were headed by Generation Z, reflecting a 43.5% increase in Gen Z’s share compared with 2023. Therefore, the rising number of pet owners is driving the growth of the companion animal diagnostics industry.Key Players In The Global Companion Animal Diagnostics Market
Major companies operating in the companion animal diagnostics market are Thermo Fisher Scientific Inc., Merck KGaA, Fujifilm Holdings Corporation, Zoetis Inc., VCA Inc., Mindray Medical International Limited, bioMérieux S.A., IDEXX Laboratories Inc., Qiagen N.V., Virbac S.A., Randox Laboratories Ltd., Esaote S.p.A., Abaxis Inc., Neogen Corporation, Arkray Inc., Indical Bioscience GmbH, Biovet S.A., Woodley Equipment Company Ltd., Scil Animal Care Company, Laboklin GmbH & Co. KG, VolitionRx LimitedGlobal Companion Animal Diagnostics Market Trends and Insights
Major companies operating in the companion animal diagnostics market are focusing on developing reference laboratories to enhance remote diagnostic capabilities and improve access to specialized care. Reference laboratories are specialized diagnostic labs that provide advanced testing services, often beyond the capabilities of standard clinical laboratories. For instance, in November 2023, Antech Diagnostics, Inc., a US-based veterinary diagnostics company, launched its first comprehensive veterinary diagnostics offering in the UK, which will include a new state-of-the-art reference laboratory located in Warwick. The new diagnostics portfolio aims to provide UK veterinary professionals with a complete and flexible range of services, including reference laboratory services, in-house diagnostics, imaging, and software solutions.What Are Latest Mergers And Acquisitions In The Companion Animal Diagnostics Market?
In June 2023, Mars Incorporated, a US-based manufacturer of confectionery and pet food, acquired Heska for an undisclosed amount. This acquisition will enable the Science & Diagnostics division of Mars Petcare to expand its diagnostic offerings. Heska Corporation is a US-based provider of companion animal diagnostics.Regional Outlook
North America was the largest region in the companion animal diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Companion Animal Diagnostics Market?
The companion animal diagnostics market consists of revenues earned by entities by providing services such as imaging services, consultation services, data management and integration services, educational and support services, and emergency diagnostic services. The market value includes the value of related goods sold by the service provider or included within the service offering. The companion animal diagnostics also includes sales of instruments and devices, test kits and reagents, molecular diagnostics, and personalized testing panels. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Companion Animal Diagnostics Market Report 2026?
The companion animal diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the companion animal diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Companion Animal Diagnostics Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $3.74 billion |
| Revenue Forecast In 2035 | $5.37 billion |
| Growth Rate | CAGR of 9.8% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Animal Type, Technology, Application, End-Users |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Thermo Fisher Scientific Inc., Merck KGaA, Fujifilm Holdings Corporation, Zoetis Inc., VCA Inc., Mindray Medical International Limited, bioMérieux S.A., IDEXX Laboratories Inc., Qiagen N.V., Virbac S.A., Randox Laboratories Ltd., Esaote S.p.A., Abaxis Inc., Neogen Corporation, Arkray Inc., Indical Bioscience GmbH, Biovet S.A., Woodley Equipment Company Ltd., Scil Animal Care Company, Laboklin GmbH & Co. KG, VolitionRx Limited |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
